Gene Profiling May Predict Treatment Response in Refractory Rheumatoid Arthritis Gene Profiling May Predict Treatment Response in Refractory Rheumatoid Arthritis

In patients with rheumatoid arthritis refractory to treatment with rituximab or tocilizumab, genetic profiling of synovial biopsies predicted the lack of therapeutic response better than a model using only tissue pathology or clinical factors, researchers say.Reuters Health Information
Source: Medscape Pathology Headlines - Category: Pathology Tags: Rheumatology News Source Type: news